Drug Safety, Год журнала: 2024, Номер 47(9), С. 841 - 842
Опубликована: Июнь 14, 2024
Язык: Английский
Drug Safety, Год журнала: 2024, Номер 47(9), С. 841 - 842
Опубликована: Июнь 14, 2024
Язык: Английский
The Pediatric Infectious Disease Journal, Год журнала: 2025, Номер 44(2S), С. S135 - S140
Опубликована: Фев. 1, 2025
Background: Tuberculosis (TB) disease during pregnancy results in adverse maternal and infant outcomes. The development of a TB vaccine with potential for administration or lactation is priority identified by the World Health Organization. We assessed acceptability vaccines currently administered [tetanus, diphtheria COVID-19] willingness to receive new and/or among Ethiopian women. Methods: From January February 2022, we conducted surveys pregnant women receiving antenatal care at 20 hospitals Amhara, Ethiopia. evaluated uptake available (diphtheria), acceptance future (COVID-19 TB) lactation, knowledge, attitudes beliefs associated vaccine-specific acceptance. Results: Among 200 participants, found high intention (90%) (92%) low COVID-19 (40%) (47%). Most participants believed vaccination would protect their child from (82.5%) have societal benefits (81.5%), while few perceived offer protection (35.5%) (42.5%). Intention was belief that prevent infants (adjusted prevalence ratio 1.37, 95% CI: 1.10–1.70). reported educational interventions increase immunization. Conclusions: Our findings support strengthen immunization programs
Язык: Английский
Процитировано
0Drug Safety, Год журнала: 2024, Номер 47(9), С. 841 - 842
Опубликована: Июнь 14, 2024
Язык: Английский
Процитировано
0